R. Schermuly (Giessen, Germany), M. Humbert (Clamart, France)
Prevention of pulmonary vascular and myocardial remodeling by the combined tyrosine and serine-/threonine kinase inhibitor, sorafenib, in pulmonary hypertension and right heart failure M. Klein, R. T. Schermuly, P. Ellinghaus, H. Milting, B. Riedl, H. A. Ghofrani, F. Grimminger, S. Schaefer (Wuppertal, Giessen, Bad Oeynhausen, Germany)
| |
Peroxisome proliferator-activated receptor gamma (PPARγ) protects against pulmonary arterial hypertension (PAH) G. Hansmann, V. A. de Jesus Perez, J. Powers, S. Schellong, L. Wang, T. Urashima, M. Rabinovitch (CA, United States Of America)
| |
In a model of genetic pulmonary hypertension, VIP attenuates pulmonary vascular remodeling and right ventricular hypertrophy S. Hamidi, T. Abdel-Razek, A. Szema, S. Said (Stony Brook, NY, Northport, NY, United States Of America)
| |
Combining bosentan and sildenafil improves mitochondrial capacity and restores right ventricular contractility in established pulmonary hypertension K. T. B. Mouchaers, I. Schalij, G. P. van Nieuw Amerongen, W. J. van der Laarse, A. Vonk Noordegraaf (Amsterdam, Netherlands)
| |
C-kit+ cell recruitment in remodelled pulmonary arteries of human PAH F. Perros, P. Dorfmuller, R. Souza, E. Fadel, S. Mussot, D. Emilie, G. Simonneau, M. Humbert (Clamart, Le Plessis Robinson, France)
| |
The effect of bortezomib (Velcade®) on endothelial progenitor cell functions in vitro T. Resch, J. Loeffler-Ragg, H. Vogelsinger, C. M. Kaehler (Innsbruck, Austria)
| |
Progression of monocrotaline-induced pulmonary hypertension in rats can be monitored by plasma activity of matrix metalloproteinase-2 and plasma levels of tenascin-C and proBNP M. Klein, F. Kramer, R. Kast, S. Schaefer (Wuppertal, Germany)
| |
RNA expression pattern of peripheral blood B-lymphocytes in idiopathic pulmonary arterial hypertension S. Ulrich, L. Taraseviciene, R. Speich, N. Voelkel (Denver, CO, United States Of America; Zurich, Switzerland)
| |